论文部分内容阅读
毛细胞白血病(简称HCL),是一种慢性罕见类型白血病。Bouronele等于1958年首次以“白血病性网状内皮增生症”而命名,清晰地描述了本病,并肯定它是一种独立的疾病。Plenderlei等于1970年开始把本病命名为HCH。目前采用免疫球蛋白重链和轻链基因密码重新排列的方法,最终归纳确定为HCL单克隆B细胞增殖疾病。国外总结报告例数较多,发病率约占白血病2～5％,国内以病例报告者为数甚少,尚缺乏统计数,
Hairy cell leukemia (referred to as HCL), is a chronic rare type of leukemia. Bouronele was first named in 1958 for “leukemia reticuloendotheliosis”, clearly describing the disease and affirming it as an independent disease. Plenderlei equal to the disease began in 1970 named HCH. At present, immunoglobulin heavy chain and light chain gene rearrangement method, finally identified as HCL monoclonal B cell proliferation disease. A large number of foreign summary report, the incidence rate of leukemia accounts for about 2 ~ 5%, the domestic case report few cases, the lack of statistics,